Recruiting NA INTERVENTIONAL 2-arm
NCT07154992
Clinical Trial to Evaluate the Efficacy of Lacticaseibacillus Rhamnosus CRL1505 in the Prevention of Upper Respiratory Tract Infections in Children
Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Lacticaseibacillus Rhamnosus CRL1505 in the Prevention of Upper Respiratory Tract Infections in a Healthy Paediatric Population
Sponsor: Bioithas SL
Conditions
Prevention Upper Respiratory Tract Infection
Interventions
Placebo Probiotic - Lacticaseibacillus rhamnosus CRL1505
Updated 1 time since 2025 Last updated: Sep 8, 2025 Started: Dec 17, 2024 Primary completion: Mar 31, 2027 Completion: Apr 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Prevention and Upper Respiratory Tract Infection, this trial is actively recruiting participants. The trial is conducted by Bioithas SL and has accumulated 1 data snapshot since 2024. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Bioithas SL
- Centro Sperimentale del Latte S.r.l.
Data source: Bioithas SL
For direct contact, visit the study record on ClinicalTrials.gov .